Locust Wood Capital Advisers LLC Takes $36.98 Million Position in Amrize Ltd $AMRZ

Locust Wood Capital Advisers LLC acquired a new position in Amrize Ltd (NYSE:AMRZ) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 761,948 shares of the company’s stock, valued at approximately $36,977,000. Locust Wood Capital Advisers LLC owned 0.14% of Amrize at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Dilation Capital Management LP acquired a new position in shares of Amrize in the 3rd quarter worth approximately $10,011,000. Nordwand Advisors LLC acquired a new position in Amrize in the third quarter valued at $6,598,000. Bfsg LLC boosted its position in Amrize by 103.9% during the third quarter. Bfsg LLC now owns 133,924 shares of the company’s stock valued at $6,499,000 after acquiring an additional 68,247 shares during the last quarter. ASR Vermogensbeheer N.V. boosted its position in Amrize by 2.3% during the third quarter. ASR Vermogensbeheer N.V. now owns 72,577 shares of the company’s stock valued at $3,502,000 after acquiring an additional 1,661 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in shares of Amrize in the 3rd quarter worth about $7,102,000.

Amrize Price Performance

NYSE:AMRZ opened at $53.60 on Thursday. The company has a current ratio of 1.45, a quick ratio of 0.97 and a debt-to-equity ratio of 0.38. Amrize Ltd has a one year low of $44.12 and a one year high of $58.11. The company has a market capitalization of $29.65 billion and a P/E ratio of 29.13. The stock’s 50-day simple moving average is $53.42.

Amrize (NYSE:AMRZ) last announced its earnings results on Wednesday, October 29th. The company reported $0.98 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by ($0.03). The company had revenue of $3.68 billion during the quarter, compared to the consensus estimate of $3.49 billion. The business’s revenue was up 6.6% on a year-over-year basis.

Wall Street Analysts Forecast Growth

AMRZ has been the topic of several research analyst reports. UBS Group upped their target price on Amrize from $53.00 to $57.00 and gave the company a “neutral” rating in a research report on Thursday, January 8th. Oppenheimer increased their price target on Amrize from $62.00 to $64.00 and gave the stock an “outperform” rating in a report on Thursday, January 15th. Zacks Research upgraded shares of Amrize from a “strong sell” rating to a “hold” rating in a research report on Friday, October 10th. Morgan Stanley set a $61.00 target price on shares of Amrize and gave the stock an “overweight” rating in a research note on Wednesday, October 29th. Finally, Stephens initiated coverage on shares of Amrize in a research note on Friday, November 14th. They issued an “overweight” rating and a $60.00 price target for the company. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $60.67.

Insider Activity

In other Amrize news, Director Nicholas C. Gangestad purchased 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 19th. The shares were acquired at an average cost of $47.34 per share, for a total transaction of $94,680.00. Following the completion of the acquisition, the director owned 4,958 shares of the company’s stock, valued at $234,711.72. The trade was a 67.61% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jaime Hill acquired 4,000 shares of Amrize stock in a transaction on Tuesday, November 4th. The stock was acquired at an average price of $50.69 per share, with a total value of $202,760.00. Following the purchase, the insider directly owned 18,101 shares in the company, valued at approximately $917,539.69. This trade represents a 28.37% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders purchased 65,000 shares of company stock valued at $3,399,720 over the last ninety days.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.